UIC Innovation awards $275,000 to support translational research

Eleven projects with high commercialization potential selected for 2022 CTRI Awards

UIC Innovation awarded $275,000 to help UIC researchers prove the viability of their ideas and advance their projects towards commercialization through the Chancellor's Translational Research Initiative (CTRI). This year's CTRI award recipients are developing emerging technologies to help diagnose and treat disease and advancing other life-saving discoveries.

Since its inception in 2018, the CTRI program has awarded $1.15 million to support translational research at UIC. The program provides up to $25,000 to help prepare early-stage projects for licensing and startup opportunities.

Meet this year's CTRI awardees:

Steven Ackerman
Department of Biochemistry and Molecular Genetics

Leslie Aldrich
Department of Chemistry

Michael Caffrey
Department of Biochemistry and Molecular Genetics

Ali Djalilian
Department of Ophthalmology and Visual Science

Michael Johnson
Center for Biomolecular Sciences

Andre Kajdacsy-Balla
Department of Pathology

Jan Kitajewski
Department of Physiology and Biophysics

Mathew Mathew
Department of Biomedical Science

John Monaghan
Department of Anthropology

Sojin Shikano
Department of Biochemistry and Molecular Genetics

Mladen Vidovich
Division of Cardiology, Department of Medicine

CTRI is a critical component of UIC’s innovation pipeline. It supports the development of disruptive technologies across a wide range of areas – from therapeutics and medical devices to engineering technologies. Successful completion of the CTRI program often leads to additional funding opportunities and enables UIC researchers to continue towards commercialization.

The program is supported by the UIC Innovation Fund, which was established to advance the commercialization of technologies developed by UIC faculty, staff and students. The fund is managed by the Office of the Vice Chancellor for Innovation in partnership with the Office of Technology Management.